Human KRAS (GTPase KRas) ELISA Kit (HUFI03662)

KRAS encodes a 21 kDa membrane-associated GTPase that operates as a binary molecular switch in the MAPK and PI3K signaling cascades. Activating mutations in this oncogene are among the most prevalent drivers of pancreatic ductal adenocarcinoma, colorectal carcinoma, and non-small cell lung cancer, making the protein a central focus of oncology research. This in vitro quantitative immunoassay from Assay Genie is supplied for research use only and offers laboratories a method to quantify KRAS protein in experimental human specimens.

The reagent set arrives configured for a microplate workflow, with coated wells, calibrators, antibodies, and detection solutions prepared for immediate assay setup. Each kit supports 96 individual determinations, accommodating both pilot investigations and larger screening efforts related to Ras effector engagement, tumor biomarker discovery, or downstream pathway analysis. Standard ELISA plate reader instrumentation is sufficient for signal acquisition, and the workflow integrates into established laboratory protocols for translational oncology, signal transduction studies, and GTPase biology research.